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Background: The study describes the initial experience and learning curve of intraoperative neuro-
monitoring (IONM) during thyroidectomy. We describe the prevalence and patterns of IONM technical
problems.
Methods: Prospective series of 152 consecutive thyroid operations (304 nerves at risk) were analyzed.
Standard technique consists of monitoring vagal and RLNs before, during and after resection. Personal
gain of experience was deﬁned by the preceding number of thyroid operations. To establish the number
of thyroidectomies required before achieving an effective and safe IONM technique, all of the procedures
were divided into three chronological groups of about 50 cases (groups 1, 2, and 3).
Results: Patients (90%) had successful IONMwith initial endotracheal tube position. Fifteen patients (10%)
needed further tube adjustment. Out of 15 patients 14 (93%) were due to non-optimal contact of
endotracheal surface electrodes to vocal cords. Tube malrotation was the main reason for initial failure
(53%). The success rates of prompt IONM technique were 80% in group 1, 92% in group 2, and 98% in
group 3 (p< 0.05). Mean operating time was low in group 3 (p< 0.03). Vagus and RLNs were localized
and monitored in all the cases (100%). The incidence of temporary RLN injury was 2.6%. No permanent
complications occurred. Negative EMG response indicated an altered function of RLN and stage
thyroidectomies were scheduled. Transient RLN palsies were seen without changes during the entire
study period.
Conclusions: This is the ﬁrst series of thyroidectomies with standardized IONM technique performed in
Italy. Neuromonitoring was effective in providing identiﬁcation and function of laryngeal nerves. IONM
successful rates were affected considerably by the extent of surgical and anaesthesiological experiences,
starting with relatively low rates in the beginner group and then increasing. We assessed the learning
curve: improved operative variables and safe technique were seen in about 50 patients.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Intraoperative neuromonitoring (IONM) has been ﬁrst proposed
as an adjunct to standard visual identiﬁcation of the recurrent
laryngeal nerve (RLN) during thyroid surgery in 1966 by Shedd.1
Experience has shown that IONM allows the laryngeal nerves,
both inferior and superior, to be reliably identiﬁed during neck
surgery.2 Authors stated that IONM is an important adjunct in
dissection and functional neural prognosis.3þ390332260260.
(G. Dionigi).
ciates Ltd. Published by Elsevier LtRecent technical advances currently allow accurate, non-inva-
sive nerve monitoring.4
With numerous institutions beginning to perform thyroidec-
tomy with IONM,5 there is an increased interest in this new device
that may facilitate the surgical procedure itself and reduce
morbidity. The prevalence of monitoring is relatively high in the
United States, United Kingdom,5 Germany,6 Asia and Oceania,7,8 as
opposed to Italy where no previous experience has been reported.
The objective of this study is to assess the role of IONM as
a means of identifying, monitoring and assessing the function of
the RLN on the performance of thyroidectomy. We describe in this
study our learning curve and the prevalence and patterns of IONM
technical problems. This would help to detect and resolve possible
equipment failure.d. All rights reserved.
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2.1. Patients
Starting in 2007, we modiﬁed our thyroidectomy procedure,
introducing the neuromonitoring for localization of RLN in all
elective bilateral thyroid operations. Between August 2007 and
May 2008, 152 consecutive patients underwent IONM thyroid
surgery, providing 304 nerves at risk for examination.
Exclusion criteria for IONM were thyroidectomies performed
with local anesthesia and missing informed consent. Moreover, 2
RLNs were excluded from this study as it featured preoperatively
cord palsy. Based on the exclusion criteria, 4 patients were with-
drawn from the present study.
Main surgical outcome measures were mean operative and
hospitalization times, intra- and postoperative complications,
technical IONM setup problems or equipment malfunction and
patient follow up.
The following complications were analyzed: intra- and post-
operative bleeding, seromas, wound infections, transient or deﬁn-
itive laryngeal nerve lesions, uni- or bilateral, permanent or
transient hypocalcemia and parathyroid gland autotransplantation.
Hypocalcemia was checked by preoperative and daily serum
calcemia, starting from the ﬁrst postoperative day and on the 7, 14
days postoperative, then 1, 3, 6 months after surgery. Intact para-
thyroid hormone (iPTH) levels were also determined post-
operatively. Signiﬁcant hypocalcemia was deﬁned as experiencing
signs or symptoms of hypocalcemia and/or having a serum calcium
level that was 7.5 mg/dL (low end of normal for assay
used¼ 8.5 mg/dL). Patients with postoperative hypocalcemia were
discharged on a therapeutic regimen of oral calcium and cholecal-
ciferol,whichwascontinueduntil normalizationof the calciumlevel.
Pre- and postoperative follow ups included for all patients direct
laryngoscopy to check vocal cord mobility performed at 24–48 h
before and within 2 weeks after the surgical procedure by an
independent laryngologist (ear, nose and throat department),
because patients may have vocal cord paralysis without changes in
their voice. Any reduction in the movement of the cord was
recorded as postoperative cord paralysis. For those patients with
documented postoperative cord palsy, repeated examinations were
performed periodically at 1, 2, 6, and 12 months after the operation
until full recovery of the vocal cord function had been conﬁrmed.
Hypoparathyroidism and RLN palsy were deﬁned as permanent
when there was no evidence of recovery within 6 months of
surgery.
Hospital discharge was at 48–72 h after the operation if no signs
of complications were present.
All procedures were performed by the same surgeon (GD) with
6 years of experience in endocrine surgery and having performed
more than 150 procedures per year in an academic setting. All
patients were intubated for general anesthesia by the same anes-
thesiologist (AB).
The attending surgeon and anesthesiologist completed a peri-
operative data sheet that included the number of applications of
IONM per case, intraoperative complications or equipment mal-
function. Moreover, we tested the hypothesis that the use of IONM
could prolong overall operative time thus intubation. We routinely
measured all the surgical procedure; in particular we classiﬁed and
calculated the anaesthetist operative time (AOT) from patient
entering the operating room to the correct endotracheal tube
placement (i.e. conﬁrmed by the correlation of EMG with respira-
tory activity). Care was taken in positioning the electrode accu-
rately, since the adjustment of the head and neck after intubations
can change the relative position of the tube and hence the elec-
trode. Furthermore, the surgical operative time (SOT) was recordedby the circulating nurse as the time from skin incision to the
application of the wound dressing.
Patients were followed pre- and postoperatively in collabo-
ration with the Division of Endocrinology of the University of
Insubria, Varese, Italy. For cancer patients, after surgery, patients
were submitted to thyroid remnant ablation by radioactive
iodine (131I) and placed under TSH-suppressive L-thyroxine
therapy.9 Preoperative diagnosis was based on ultrasound-guided
ﬁne needle aspiration cytology and serum calcitonin
measurement.92.2. Operative technique
The technique of IONM was standardized and has been
described.4,6 Succinylcholine (1 mg/kg) was used in the initial
phase of the general endotracheal anesthesia. No additional
neuromuscular blocking agents were used following intubation.
The Nerve Integrity Monitor (NIM-Response 2.0 System, Medtronic
Xomed, Jacksonville, Florida) was used for laryngeal nerves moni-
toring. A dedicated tube (NIM Contact EMG Tube) is used and
functions as a normal endotracheal tube, except that it contains
bipolar, stainless steel contact electrodes for monitoring both vocal
cords. The tube is placed with the exposed electrodes well in
contact with the true vocal cords under direct laryngoscopy.
RLN is located, mapped and stimulated in the surgical ﬁeld by
the application of a sterile single-use pulse-generated monopolar
stimulator probe (no. 8225101, Medtronic Xomed). This stimulator
measured 10 cm in handle, 9 cm long in probe with a ﬂexible and
adaptable tip of 0.5 mm. The probe delivers an electric current that
ranged from 0.5 to 2 mA. The probe is insulated at the tip to prevent
current shunting. The identity of an intact nerve is conﬁrmed
through a series of audible acoustic signals generated by the
machine. The probe is applied directly, perfectly and minutely to
the nerve for approximately 1 s to elicit a response. The stimulation
level was set at 0.5 mA as a starting point; if no signal was elicited,
the stimulation was increased. Equipment failure was considered if
pre-resection vagal stimulation signal could not be received at
a level of 2.0 mA.
Our standard IONM technique is to stimulate both the vagus
nerve and the RLN before, during and after thyroid resection.4,6,10
The ispilateral vagus nerve is stimulated directly by a 1–3 cm
dissection of the carotid sheath or in some cases only by simply
applying the stimulator on the carotid shift without dissection
(usually in patients with low fat in the neck). The absence of a signal
that was generated by the stimulator at any precise point along the
nerve would be regarded as a positive test. Nonpathologic and
pathologic EMG responses were recorded. The identiﬁcation of the
disrupted point was located by stimulating the distal point of
the RLN at the entry to the larynx and the proximal portion of the
exposed RLN to the upper portion until a signal was elicited. Thus,
the disrupted point could be located and potentially pinpointed.
To gain experience in this ﬁeld, scientiﬁc background of the ﬁrst
author included two University internships at the Thyroid and
Parathyroid Surgical Division, Harvard Medical School, Boston
(USA) and the Department of General Surgery, Martin Luther
University, Halle (Germany).
Personal gain of experience was deﬁned by the preceding
number of thyroid operations. All operations were indexed
consecutively with a running number.
Option for controlling haemostasis during thyroidectomy
included the vessel sealing system (LigaSure, Precise, Valley Lab).
If a parathyroid gland appeared to be damaged or hypovascu-
larized, we reimplanted it in the sternocleidomastoid muscle. No
patients received antibiotics prophylaxis.11
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According to Chiang and Dralle,6,10 loss of IONM signal was
deﬁned as true positive (TP) if RLN palsy was conﬁrmed on post-
operative laryngoscopy; false positive (FP) with a no veriﬁable RLN
palsy. Intact IONM signal was deﬁned as false negative (FN) in case
of RLN palsy diagnosed on postoperative laryngoscopy and true
negative (TN) with normal postoperative laryngoscopic ﬁnding.
Sensitivity was calculated as TP/(TPþ FN); speciﬁcity as TN/
(FPþ TN). Positive predictive value (PPV): TP/(TPþ FP); negative
predictive value (NPV): TN/(FNþ TN) and accuracy: TPþ TN/total
number.
Unless otherwise stated, all data for continuous variables were
expressed as median and range. All patients’ data were collected in
a prospective manner with a dedicated electronic Microsoft Ofﬁce
Access Database (Microsoft Corp, Redmond, Washington). Data are
collected daily until the day of discharge, then there was a regular
contact between the study coordinator and the participating
specialist (endocrinologist, laryngologist, etc.). The database is part
of our department’s quality-improvement program. The use of this
database for clinical research has been approved by our institu-
tional review board. Primary outcome measure was the morbidity
and mortality. In case of dichotomous variables, group differences
were examined by c2 or Fisher exact tests as appropriate. Statistical
analysis was computed with SPSS, release 15.0 for Windows (SPSS
Inc, Chicago–Ill, USA) in cooperation with the Institution of
Biomedical Statistics of the University of Insubria. The level of
signiﬁcance was set at p less than 0.05. All efforts were made to
avoid sources of bias such as the loss of individuals to follow up
during the study.
3. Results
The study group included 97 women and 55 men with a mean
age of 39.8 (age range 19–77 years). The mean thyroid volume
estimated by preoperative ultrasonography was 41 (range 11–
149) mL. Mean size of dominant nodules was 3.5 cm (range 1.2–
7.9 cm). The treated pathologies were mainly nodular goiter and
tumors (Table 1). Complete follow up was available for all
patients.
3.1. IONM setup
About 137 (90%) patients had successful IONM with the initial
endotracheal tube position. Fifteen (10%) patients needed further
tube adjustment under ﬁberoptic bronchoscopy (initialTable 1
Preoperative characteristics and operative parameters in 152 patients undergoing
elective bilateral thyroidectomy with IONM.
N
Age (years) 39.8 (19–77)
Women 97
Men 55
Thyroid volume (mL)a 41 (11–149)
Dominant nodule diameter (cm) 3.5 (1.2–7.9)
Nerves at risk 304
Thyroid pathology
-Non toxic nodular goiter 88 (58)
-Hyperthyroidismb 39 (26)
-Thyroid cancerc 25 (16)
Data are numbers or mean with percentages or ranges in parentheses.
a Estimated by preoperative ultrasonography (US).
b Toxic nodular goiter (n¼ 23), Graves’s disease (n¼ 16).
c Papillary carcinoma (n¼ 19), follicular carcinoma (n¼ 5), and medullary carci-
noma (n¼ 1).unsuccessful monitoring). All these patients (15/15 patients, 100%)
had no EMG signal on the ﬁrst pre-resection vagal nerve stimula-
tion. Speciﬁc reasons for initial unsuccessful IONM were tube
malrotation in 8 patients (53%); in 5 patients (33%) the endotra-
cheal surface electrodes were inserted too deep (n¼ 4) (mean
23.25 cm, range 22–24 cm from oral) or too high (n¼ 1); improper
tube size in 1 patient (7%); and displacement of the external sternal
wires in 1 case (7%).
As for tube malrotation, 6 of the 8 patients (75%) were towards
the right side (clockwise tube turn following intubation).
In the only case of improper tube size, the tube tends to rotate
clockwise; in this case, the anesthesiologist needs to change the
dedicated tube with a bigger one of one size, from 7 mm to 8 mm
internal diameter (ID).
Thus, in 93% of cases (14/15), causes of unsuccessful IONM were
due to a non-optimal contact of the endotracheal surface electrodes
to the vocal cords (Table 2).
After adjustment of tube position and electrodes, all patients
had ﬁnal successful IONM prior thyroid resection with optimal
vagal EMG signal.
To establish the number of thyroidectomies required before
achieving an effective and safe IONM technique, all of the proce-
dures were divided into three chronological groups of about 50
cases (groups 1, 2, and 3). There were no statistical difference
between the three groups for distribution of epidemiological
characteristics, thyroid pathology, and mean weight of the thyroid
(p> 0.05) (data not shown). There were 10 unsuccessful cases in
group 1, 4 cases in group 2, and 1 in group 3. Thus, the success rates
of prompt IONM technique were 80% (40/50 patients) in group 1,
92% (46/50 patients) in group 2, and 98% (49/50) in group 3,
respectively (p< 0.05). Details of each group are shown in Table 3.
There was no correlation between epidemiological characteris-
tics, thyroid volume, thyroid pathology and the equipment mal-
functions (data not shown).
The overall mean operative time was 91.6 (range 59–130) min.
In group 1, the overall mean operative timewas 111.0 (78–139) min,
while operative time in group 2 was 93 (66–134) min and group 3
86 (59–130) min (p< 0.03). Both AOT and SOT of group 1 were
signiﬁcantly higher than groups 2 and 3.
The mean supramaximal current was 1 mA. The maximal
current used for supramaximal stimulation was 1.5 mA, and the
minimal current was 0.5 mA.
The nerve stimulator/probe was applied a mean of 13 times
(range 8–19 times) per case, for a total of 1798 applications. There
were no signiﬁcant differences in the number of probe applications
per period study, thyroid volume or treated pathologies (data not
shown).Table 2




Insertion to deepb 4 26
High insertion 1 7
Improper tube sizec 1 7
External wires
Displacement of sternal wires 1 7
Total 15 10 (15/152)
About 93% (14/15) non-optimal contact of endotracheal surface electrodes to the
vocal cords.
a About 6/8, 75% clockwise rotation to right.
b Mean 23.25 cm, range 22–24 cm from oral.









Group 1 Group 2 Group 3 
Unsuccessful IONM
Successfull IONM
Group 1ðfrom first IONM thyroidectomy to 50thÞ :
IONM successful rate 80% ð40=50patientsÞ
Group 2ðfrom 51st to100Þ :
IONM successful rate 92% ð46=50Þ p < 0:05g
Group 3 (from 101 to 152): IONM successful rate 98% (49/50)
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As for systemic interaction, we found no cardiac interaction
(arrhythmia), no pulmonary (bronchospasm) interaction intra- and
postoperatively due to vagal nerve stimulation. No patient had any
motility disorders of the gastrointestinal tract postoperatively.
About 76% of patients experienced a 48 h hospital stay, 24% of
patients a 72 h stay.
No mortality was observed. Overall morbidity was as high as
16.4% (N¼ 25) and in most cases included transient complications
(Table 4).
No patient required reoperation. There were no other peri-
operative incidents: in particular no hemorrhagic complications or
cervical hematoma was observed. One patient experienced
a wound seroma. One patient reported wound infection.
No bilateral vocal cord paresis or paralysis occurred in the study
period. There was 1 case of permanent hypocalcemia. No case of
permanent RLN paralysis was reported in the study group.
The incidence of temporary hypoparathyroidism was 11.8% (18/
152). One patient was readmitted with a diagnosis of symptomatic
hypocalcemia 2 days after discharge.
The vagus nerve and the RLN were intraoperatively correctly
localized and monitored bilaterally in all cases (100%, 304 nerves at
risk). The overall incidence of temporary RLN injury was 2.6% (4
patients). Transient recurrent nerve palsies were seen without
changes during the entire study period. Loss or decrease in
amplitude of EMG signals was seen in all these patients with RLN
injury (true positive IONM signal, 100%).Table 4
Morbidity.
N (%)
Wound complication 2 (1.3)
Permanent hypoparathyroidism 1 (0.65)
Permanent RLN injury 0
Temporary hypocalcemia 18 (11.8)
Temporary RLN injury 4 (2.6)
Total 25 (16.4%)In detail, a modiﬁed EMG amplitude signal was seen in 2
patients during the ﬁrst lobectomy (two left lobectomies); in 2
patients during the second lobectomy (one right, one left RLNs).
The ﬁrst 2 patients were scheduled for a total thyroidectomy for
a bilateral diffuse multinodular goiter (one video-assisted
thyroidectomy). The procedures were stopped after the ﬁrst
lobectomy to avoid the potential for bilateral vocal cord paralysis
(one-stage thyroidectomy). 4,6,10 Early intraoperative and post-
opearative steroid administration was given. Both patients were
dysphonic and laryngoscopy performed at 48 h postoperatively
conﬁrmed a reduction in the movement of the left vocal cord. A
repeated examinationwas performed at 1, 2, and 3months after the
operation until full recovery of vocal cord function was conﬁrmed
after speech therapy. The patients underwent complete thyroid-
ectomy after 3 and 4 months, respectively, from ﬁrst operation
without complications.
Patients 3 and 4 had a minimal vocal cord dysfunction which
was diagnosed laryngoscopically. Full recovery of vocal cord func-
tion was conﬁrmed after logopedy at 2 and 6 months
postoperatively.
By mapping with IONM the cervical course of the RLN, proxi-
mally and distally, we found in all cases the disrupted point of
conduction. In detail, in 3/4 cases the RLN was injured in last 2 cm
of its course, in 1 case more proximally. In all these cases an
external RLN branching was present. Visually it was hard to judge
the nerve injury in 3/4 cases (probably was a stretch or blunt
injuries).
Postoperative laryngoscopy conﬁrms no case of false negative
IONM signal.
We were not involved in any lawsuit as a result of these RLN
injuries.
4. Discussion
The availability of a non-invasive monitoring device for RLN led
us to introduce this tool for all elective bilateral thyroid procedures.
To our knowledge, this is the ﬁrst series of patients undergoing
thyroidectomy with the use of IONM in Italy.
Standardization of IONM technique, surgical training, speciﬁc
experience and a interdisciplinary collaboration are essential for
optimal use of this new device.
A standardized technique includes both vagal and RLNs stimu-
lation before, during and after thyroid resection. This is in concor-
dancewith Timmermann, Dralle and Chiang remarks.4,6,10 Based on
the same principle, Ulmer developed a real-time RLN monitoring
by continuous stimulation of the vagal nerve with an implanted
tripolar cuff electrode.12 Pre-resection vagal nerve stimulation has
the advantage to detect equipment failures early before thyroid-
ectomy.4,6,10 Vagus and RLNs stimulation during and after resection
prove RLN anatomy and function.4,6,10
Using the neuromonitoring procedure we were able to exclude
the presence of RLN in each step of dissection and ligation. A
negative EMG response indicates a non-nerve structure or altered
function of the RLN. IONM allowed us to stage contralateral surgery
if RLN damage is diagnosed at ﬁrst lobectomy, thereby avoiding the
potential for bilateral vocal cord paralysis. No bilateral paralysis was
diagnosed in the study period. In the case of patients with pre-
existing RLN morbidity, intraoperative assessment of RLN function
with IONM may facilitate reoperations.6 Moreover, all patient with
intraoperative diagnose of RLN injury were given early intra-
operative and postopearative steroid administration.13
With IONMwewere able to locate routinely the disrupted point
of conduction of RLN (immediately and intraoperatively) in all cases
with lost or decrease EMG signal. Several studies have shown how
poor the surgeon is at judging RLN injury intraoperatively.14–16 RLN
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crush, electrical injury, ligature, ischemia, or suction injury without
transaction.10,17 In this study, in 3/4 cases (75%) the injured RLN
appears intact to the surgeon’s eye. Other authors found that in
only 1 of 10 cases of RLN injury were surgeons aware of the
injury.14–16
IONM in thyroid surgery is appealing. However, the adoption of
this technique is hampered by the steep learning curve and the fear
of exposing patients to excessive prolongation of operative time
and morbidity. Equipment malfunction or improper endotracheal
tube position can result in unsuccessful monitoring which could
potentially give rise to misleading information that might increase
the risk of RLN injury.18 We assessed how many patients should be
monitored to overcome this learning curve. In this study, the
success rates of IONM technique were considerably associated with
experience. A clear turning point, with improved operative vari-
ables and safe IONM technique, was seen in about 50 patients. In
fact, patients were not exposed to excessive morbidity during this
learning curve. Vagal nerve stimulation did not cause any cardiac,
pulmonary, or gastrointestinal interaction. The procedural mal-
functions signiﬁcantly decreased after the ﬁrst 50 procedures. The
length of operation decreased after the ﬁrst 50 cases. Other authors
stated that the intraoperative neuromonitoring in thyroid surgery
is associated with a longer learning curve lasting several years.19 A
minimum of 100 operations using IONM are required according to
Dralle.20
In this study, 93% of unsuccessful IONM cases were due to a non-
optimal contact of the endotracheal surface electrodes to the vocal
cords for displacement. The position of the electrodes can be dis-
placed and not be detected when the patient’s head and neck
position is changed from the initial for tracheal intubation to full
extension for thyroid surgery.18 Displacement must be detected
easily by checking the impedance imbalance of the NIM EMG
monitor.
The study represents the result of the collaboration at the
University Hospital of Varese between the Department of Surgical
Sciences, the Division of Endocrinology, Anesthesiology and
Neurology. Our good results of IONM can be explained by
a combination of conscientious preparation of the equipment and
the routine and experience of the multidisciplinary team. In fact,
each IONM thyroidectomy was performed cooperatively with
different specialties. This is in concordance with the interdisci-
plinary neuromonitoring study groups recently proposed in liter-
ature.4,6 Moreover, surgeons need to implement all their
knowledge with this new technology and be experienced in
neurophysiology to make optimal surgical decision for their
patients: in fact, IONM provides original data on RLN and vagal
neurophysiology and pathology.6
IONM in thyroid surgery has, more than any other new tech-
nology, created extreme controversy and debate, particularly
within the establishment.8,21,22 On reﬂection this is not surprising
given that few specialist surgeons are trained to do it. With
continuous technical reﬁnements, learning curve and experience,
more patients could become candidates for IONM.5 Currently, in
our academic setting, residents use the RLN monitoring during
their training in endocrine surgery. The use of neuromonitoring
provides new instructive information for operation by ascertaining
where and how the RLN has been injured.
IONM during thyroidectomy may be easily organized in centers
of endocrine surgery. However, most patients with thyroid prob-
lems are still treated in smaller surgical units in Italy. Therefore,
IONM may be a logistical problem.
IONM has been claimed in some studies to reduce rates of nerve
injury, whereas other studies have found no beneﬁt.8,23 Hermann
concluded in a prospective study that neuromonitoring is useful foridentifying the recurrent laryngeal nerve, in particular if the
anatomic situation is complicated by prior surgery, large tissue
masses.24 In this study, RLN palsy still occurred with routine
identiﬁcation of RLN combined with IONM, although all cases were
temporary. No permanent palsies were diagnosed in the study
period. Studies have shown that only routine exposure of the RLN is
associated with very low rates of injury in high volume centers.25,26
A signiﬁcant reduction in the rates of postoperative complications
was not possible to be demonstrated in the present study. In order to
compare the use of IONM, a multi-center trial with large numbers
and well-deﬁned groups is needed. Eisele noted that to show
a reduction in RLN paralysis rates from 2% to 1% per nerve at risk,
a study group of approximately 1000 patients would be necessary.27
The gold standard is still thyroidectomy with routine visuali-
zation of the RLN: this approach is essential in case of malfunction
of this novel technology.
There are other criticisms on the use of IONM, focusedmainly on
the cost: the device is expensive. In consideration of its cost, we did
not perform any statistical study in this study. Recently, authors
stated that the implementation of the clinical pathway for thyroid
operations had successfully reduced clinically variability, hospital
stay and mean cost.28
Perhaps, the monitoring of nerves during surgical procedures
potentially reduces the medico-legal liability for surgeons.29Competing interest
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